Company Filing History:
Years Active: 1998-2015
Title: Vinod Dipak Parikh: Innovator in Cognitive Healthcare
Introduction: Vinod Dipak Parikh is a notable inventor based in Mystic, Connecticut. With four patents to his name, he has made significant contributions to the field of cognitive healthcare, particularly through his work on innovative treatments for psychiatric and neurological disorders.
Latest Patents: Vinod's most recent patents involve KAT II inhibitors. These compounds are described by the formula that includes variables X, Y, Z, R, and pharmaceutically acceptable salts. They are specifically targeted for the treatment of cognitive deficits associated with schizophrenia and other psychiatric, neurodegenerative, and neurological disorders in mammals, including humans. The dual nature of these patents highlights the importance of his research and its potential impact on therapeutic approaches.
Career Highlights: Vinod Parikh is currently associated with Pfizer Corporation, a leading global biopharmaceutical company. His role within this prestigious organization underscores his commitment to advancing medical science and health outcomes through innovative therapies. His expertise plays a crucial role in developing treatments aimed at improving cognitive function in affected populations.
Collaborations: Throughout his career, Vinod has collaborated with notable colleagues, including Amy Beth Dounay and Laura Ann McAllister. This collaborative approach fosters an environment of innovation and enhances the effectiveness of the research being conducted.
Conclusion: Vinod Dipak Parikh's contributions to the field of cognitive healthcare through his groundbreaking patents make him a significant figure in the realm of innovation. His ongoing research at Pfizer Corporation reflects a dedication to improving the quality of life for those affected by cognitive deficits. As the landscape of psychiatric and neurological treatment continues to evolve, inventors like Vinod remain at the forefront, driving progress and hope for new therapeutic solutions.